Joshua Gagne
Associate Professor
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
Department of Epidemiology, Harvard T.H. Chan School of Public Health
Contact
Recent Publications
- Methodologic considerations for noninterventional studies of switching from reference biologic to biosimilars
- Controlling Confounding in a Study of Oral Anticoagulants: Comparing Disease Risk Scores Developed Using Different Follow-Up Approaches
- Non-Vitamin K Antagonist Oral Anticoagulants and Angioedema: A Cohort and Case-Crossover Study
-
@RachBarenie 31 points for Kombiglyze plus another 9 for XR. That’s currently 2nd place for one word names and 2nd place overall counting the XR.
-
@anecdatally 34 points!! That tops Xeljanz and Zyprexa for one-word names.
-
I have another fun (and perhaps more original) drug name games that I'll roll out next week. Stay tuned.
-
@DrewBoberts I should have specified one-word responses only! 😀Nevertheless, 46 points -- well done! After Xeljanz, Zyprexa alone is the next highest-scoring single-word brand drug name that I can think of -- 28 points.
-
@khaynes001 Correct!